CTx-1301 PDUFA Date (Cingulate)
FDA PDUFA decision date for CTx-1301 is May 31, 2026. Developed by Cingulate. Indication: ADHD (children and adults). Current status: Verifying.
Indication
ADHD (children and adults)
Regulatory details
- Company: Cingulate
- Therapeutic area: Neurology / CNS
- Application type: NDA
- Review type: Standard
- PDUFA date: 2026-05-31
- Outcome: Pending